RACHEL KIZUKA: Open Payments
NPI 1841847167 · PALO ALTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$921 in 33 payments from 6 companies in 2025. Trend: 2023 $164 · 2024 $246 · 2025 $921
Food & beverage: $921
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $450 |
| ABBVIE INC. | 10 | $210 |
| GENZYME CORPORATION | 1 | $123 |
| Lilly USA, LLC | 3 | $95 |
| PFIZER INC. | 1 | $24 |
| Braintree Laboratories, Inc. | 1 | $19 |
Products named: TREMFYA, DUPIXENT, RINVOQ, OMVOH, CREON, LINZESS, VELSIPITY, SUFLAVE.
Industry payments across CA — which companies pay providers there.
